Children's Hospital Medical Center, Cincinnati

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Children's Hospital Medical Center, Cincinnati sits in the top decile of US sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count).

571 total trials 106 currently recruiting 372 completed early-phase tilt top decile by trial count

Children's Hospital Medical Center, Cincinnati: 571 sponsored US clinical trials, 106 recruiting.

Children's Hospital Medical Center, Cincinnati sponsors 571 registered US clinical trials on ClinicalTrials.gov, 106 of them currently recruiting, and 372 completed. 38 of these trials are in Phase 3-4 (later-stage) and 140 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 13 trials.

Top-decile sponsor footprint

Children's Hospital Medical Center, Cincinnati ranks in the top decile of sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

372 of 412 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

571 total, page 10 of 12

TERMINATED NA

Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease

NCT01671579

COMPLETED NA

Improving Medication Adherence in Pediatric Inflammatory Bowel Disease

NCT01536509

COMPLETED NA

Pilot Study: Safety of a Customized MRI System for Neonatal Imaging

NCT01522339

COMPLETED NA

Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD

NCT02511782

COMPLETED Phase 2

Losartan to Reverse Sickle Nephropathy

NCT01479439

COMPLETED NA

Patterned Experience for Preterm Infants

NCT01577615

COMPLETED

Patient Controlled Analgesia Pharmacogenetic Study

NCT01731873

COMPLETED Phase 1

Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children

NCT01521130

COMPLETED

Use of Specially Designed Pediatric MR Coils on Clinical Scanners

NCT01795989

COMPLETED NA

NIRS Guidance Trail in Children's Heart Surgery

NCT02157597

COMPLETED

Ontogeny of Infantile Hemangiomas With Skin Imaging Modalities

NCT02061735

COMPLETED Phase 1

Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock

NCT01352182

COMPLETED NA

Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass

NCT01709227

TERMINATED Early Phase 1

A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma

NCT01466855

COMPLETED NA

Sleep Organization in Premature Infants With Feeding Difficulties

NCT01946308

COMPLETED

Pediatric Aggression and Violence

NCT01253343

COMPLETED Phase 1

Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)

NCT01435811

TERMINATED NA

Use of Biomarkers to Optimize Fluid Dosing,CRRT Initiation and Discontinuation in Pediatric ICU Patients With AKI

NCT01416298

COMPLETED

CT Residual Gastric Fluid Volume

NCT02239068

COMPLETED NA

Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease

NCT02200510

COMPLETED Phase 2

Pilot Study of Melatonin and Epilepsy

NCT00965575

COMPLETED NA

Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT01352468

COMPLETED NA

Improving Sexually Transmitted Infection (STI) Results Notification and Partner Services

NCT01938053

TERMINATED Phase 2

High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors

NCT05167370

COMPLETED Early Phase 1

Intervention to Reduce Body Burdens of PCBs in Residents of Anniston, Alabama

NCT01261338

COMPLETED NA

Repetitive Transcranial Magnetic Stimulation to Reduce Tics

NCT01258790

COMPLETED

Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up

NCT01884220

COMPLETED NA

Usage, Usability & Effect on Adherence and Clinical Outcomes of Text Message Reminders for Adolescents With Asthma

NCT01253330

COMPLETED

Multicenter Perioperative Opioid Pharmacogenetic Study

NCT01495611

COMPLETED Phase 1

Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy

NCT01207908

COMPLETED Phase 1

Susceptibility of Human Volunteers With Different Histo-Blood With Different Histo-Blood Group Antigens to Norovirus

NCT01322503

COMPLETED

Vitamin D Status and the Adequacy of Vitamin D Intake in Early Preterm Infants

NCT01793402

COMPLETED NA

Treatment of Maternal Depression in Home Visitation: Mother and Child Impacts

NCT01212783

TERMINATED Phase 2

CD34+ Stem Cell Infusion to Augment Graft Function

NCT01856582

COMPLETED Phase 1

Trial of Zileuton CR in Children and Adults With Sickle Cell Disease

NCT01136941

COMPLETED NA

Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT01176136

COMPLETED NA

Cognitive Training Trial

NCT01133418

COMPLETED

Defining Axonal Injury in Children With Mild Traumatic Brain Injury

NCT01922531

COMPLETED

Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease

NCT01821287

COMPLETED Phase 1

Dosing of Levetiracetam (Keppra) in Neonates

NCT01239212

COMPLETED NA

Teaching Injury Prevention

NCT01958099

COMPLETED Phase 2

Comparing School Based Interventions for Adolescents With Attention Deficit Hyperactivity Disorder

NCT00947973

COMPLETED NA

Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis

NCT01173159

COMPLETED Phase 4

Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care

NCT01143701

COMPLETED Phase 2

Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis

NCT01104025

COMPLETED NA

Rehabilitation Research and Training Center for Traumatic Brain Injury Interventions--Teen Online Problem Solving Study

NCT01042899

COMPLETED Phase 1

Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00867451

COMPLETED Phase 1

Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)

NCT01070316

COMPLETED NA

Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies

NCT02038894

COMPLETED NA

Internet-based Interacting Together Everyday, Recovery After Childhood TBI (I-InTERACT)--RRTC

NCT01214694

← Previous Page 10 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 86
Phase 2 54
Phase 3 15
Phase 4 23

What is open in the Children's Hospital Medical Center, Cincinnati pipeline

106 recruiting of 571 indexed (19% open); 372 completed (65%).

Phase mix: 38 late (III/IV) vs 140 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Children's Hospital Medical Center, Cincinnati: open-pipeline peers nationwide

Peers matched on 571 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 5%10%15%20%25%30% Total trials Recruiting share Children's Hospital Medical Center, CincinnatiNational Institute of Neurological Disorders and Stroke (NINDS)City of Hope Medical CenterUniversity of Maryland, BaltimoreAmgenArkansas Children's Hospital Research InstituteUniversity of Missouri-ColumbiaMclean HospitalMontefiore Medical Center
Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 571 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Children's Hospital Medical Center, Cincinnati page

571 registered trials is a research-attention snapshot, not an endorsement of Children's Hospital Medical Center, Cincinnati or any single study.

  • 106 of Children's Hospital Medical Center, Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autism Spectrum Disorder is the condition Children's Hospital Medical Center, Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Children's Hospital Medical Center, Cincinnati pipeline card: 571 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.